Fixation of tibial plateau fractures with synthetic bone graft versus natural bone graft: a comparison study.
OBJECTIVE
The goal of this study was to determine differences in fracture stability and functional outcome between synthetic bone graft and natural bone graft with internal fixation of tibia plateau metaphyseal defects.


METHODS
Hydroxyapatite calcium carbonate synthetic bone graft was utilised in 14 patients (six males and eight females). Allograft/autograft were utilised in the remaining 10 patients (six males and four females). All the 24 patients had clinical, radiological and subjective functional score assessments.


RESULTS
There was no significant statistical difference between the groups for post-operative articular reduction, long-term subsidence, and WOMAC scores. The degree of subsidence was not related to age or fracture severity. Maintenance of knee flexion was found to be better in the allograft/autograft group (p = 0.048) when compared between the groups. Multivariate analysis compared graft type, fracture severity, post-operative reduction, subsidence rate, range of movement and WOMAC score. The only finding was a statistical significant association with the graft type related to the 6-month range of movement figures.


CONCLUSIONS
Use of autologous or allogenic bone graft allows better recovery of long-term flexion, possibly due to reduced inflammatory response compared with synthetic bone composites. However, all other parameters, such as maintenance of joint reduction and subjective outcome measures were comparable with the use of hydroxyapatite calcium carbonate bone graft. This study shows that synthetic bone graft may be a suitable alternative in fixation of unstable tibia plateau fractures, avoiding risk of disease transmission with allograft and donor site morbidity associated with autograft.
Department of Trauma and Orthopaedics, Cork University Hospital, Wilton, Cork, Ireland. josh.cy.ong@gmail.com
J C Y
JC
Ong
M T
MT
Kennedy
A
A
Mitra
J A
JA
Harty
D000328:Adult; D000368:Aged; D001672:Biocompatible Materials / Q000627:therapeutic use*; D016025:Bone Transplantation; D005260:Female; D005593:Fracture Fixation, Internal; D006801:Humans; D006882:Hydroxyapatites / Q000627:therapeutic use*; D007719:Knee Joint / Q000502:physiology; D008297:Male; D008875:Middle Aged; D016059:Range of Motion, Articular; D013978:Tibial Fractures / Q000601:surgery*
D001672:Biocompatible Materials; D006882:Hydroxyapatites